Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Performance status and quality of life in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma receiving afamitresgene autoleucel
Michael J. Wagner, Colin Lunt, Dejka M. Araujo, Jean Yves Blay, Mihaela Druta, Steven Attia, Claudia Maria Valverde Morales, Kristen N. Ganjoo, Scott M. Schuetze, Sandra P. D’Angelo, Elizabeth T. Loggers, Albiruni Abdul Razak, Édouard Forcade, Sandra J. Strauss, Erin Van Winkle, Peter Bayer, Jane P. F. Bai, D. Bestul, Viral Desai, Murray Yule, Dennis Williams, Elliot Norry, Brian A. Van Tine (2025). Performance status and quality of life in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma receiving afamitresgene autoleucel. , 4, DOI: https://doi.org/10.1016/j.esmorc.2025.100025.
Article22 days agoA phase 1, first-in-human study of DS-2243, an HLA-A*02/NY-ESO–directed bispecific T-cell engager, in patients with advanced solid tumors.
Sandra P. D’Angelo, Vivek Subbiah, Jean Yves Blay, Michael J. Wagner, Neeltje Steeghs, Jeonghwan Youk, Hideki Mizusako, Yoshihiro Ohue, Jin Jin, Abdul Waheed Rajper, Nicole Tesar, Patrick Schöffski (2025). A phase 1, first-in-human study of DS-2243, an HLA-A*02/NY-ESO–directed bispecific T-cell engager, in patients with advanced solid tumors.. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.tps2668.
Article22 days agoSupplementary Table 3 from A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors
J. Andrew Livingston, Jean Yves Blay, Jonathan C. Trent, Claudia Valverde, Mark Agulnik, Mrinal M. Gounder, Axel Le Cesne, Meredith McKean, Michael J. Wagner, Silvia Stacchiotti, Samuel Agresta, Alfonso Quintás‐Cardama, Sarah A. Reilly, Kathleen Healy, Denice Hickman, Tina Zhao, Alex Ballesteros‐Perez, Alexis Khalil, Michael P. Collins, Jessica Piel, Kim Horrigan, Ariel Lefkovith, Scott Innis, Alexander J. Lazar, Gregory M. Coté, Andrew J. WagnerSupplementary Table 3 from A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors. , DOI: https://doi.org/10.1158/1078-0432.28428216.
Dataset22 days agoSupplementary Table 8 from A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors
J. Andrew Livingston, Jean Yves Blay, Jonathan C. Trent, Claudia Valverde, Mark Agulnik, Mrinal M. Gounder, Axel Le Cesne, Meredith McKean, Michael J. Wagner, Silvia Stacchiotti, Samuel Agresta, Alfonso Quintás‐Cardama, Sarah A. Reilly, Kathleen Healy, Denice Hickman, Tina Zhao, Alex Ballesteros‐Perez, Alexis Khalil, Michael P. Collins, Jessica Piel, Kim Horrigan, Ariel Lefkovith, Scott Innis, Alexander J. Lazar, Gregory M. Coté, Andrew J. WagnerSupplementary Table 8 from A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors. , DOI: https://doi.org/10.1158/1078-0432.28428201.
Dataset22 days agoSupplementary Table 5 from A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors
J. Andrew Livingston, Jean Yves Blay, Jonathan C. Trent, Claudia Valverde, Mark Agulnik, Mrinal M. Gounder, Axel Le Cesne, Meredith McKean, Michael J. Wagner, Silvia Stacchiotti, Samuel Agresta, Alfonso Quintás‐Cardama, Sarah A. Reilly, Kathleen Healy, Denice Hickman, Tina Zhao, Alex Ballesteros‐Perez, Alexis Khalil, Michael P. Collins, Jessica Piel, Kim Horrigan, Ariel Lefkovith, Scott Innis, Alexander J. Lazar, Gregory M. Coté, Andrew J. WagnerSupplementary Table 5 from A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors. , DOI: https://doi.org/10.1158/1078-0432.28428210.
Dataset22 days ago